We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | NASDAQ:ATOS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.53 | 1.45 | 1.53 | 0 | 09:18:45 |
From May 2022 to May 2024
Mr. Guse will be available for one-on-one meetings. To request a meeting and to register for the conference, click below:
https://hcwevents.com/annualconference/
About Atossa Therapeutics
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and COVID-19.
For more information, please visit www.atossatherapeutics.com
Contact:
Atossa Therapeutics, Inc.Kyle Guse, General Counsel and Chief Financial Officerkyle.guse@atossainc.com
1 Year Atossa Therapeutics Chart |
1 Month Atossa Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
